WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010027405) FORMULATIONS OF GC-C RECEPTOR AGONIST POLYPEPTIDES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/027405    International Application No.:    PCT/US2009/004685
Publication Date: 11.03.2010 International Filing Date: 14.08.2009
IPC:
A61K 9/20 (2006.01), A61K 9/48 (2006.01), A61K 38/00 (2006.01), A61K 47/02 (2006.01), A61K 47/18 (2006.01)
Applicants: IRONWOOD PHARMACEUTICALS, INC. [US/US]; 301 Binney Street Cambridge, MA 02142 (US) (For All Designated States Except US).
FRETZEN, Angelika [DE/US]; (US) (For US Only).
WITOWSKI, Steven [US/US]; (US) (For US Only).
GROSSI, Alfredo [US/US]; (US) (For US Only).
ZHAO, Hong [CN/US]; (US) (For US Only)
Inventors: FRETZEN, Angelika; (US).
WITOWSKI, Steven; (US).
GROSSI, Alfredo; (US).
ZHAO, Hong; (US)
Agent: O'BRIEN, Jonathan, P.; Honigman Miller Schwartz & Cohn LLP 350 East Michigan Avenue, Suite 300 Kalamazoo, MI 49007-3800 (US)
Priority Data:
61/094,327 04.09.2008 US
Title (EN) FORMULATIONS OF GC-C RECEPTOR AGONIST POLYPEPTIDES
(FR) FORMULATIONS SOLIDES STABLES DE POLYPEPTIDES AGONISTES VIS-À-VIS DU RÉCEPTEUR GC-C SE PRÊTANT À UNE ADMINISTRATION PAR VOIE ORALE
Abstract: front page image
(EN)Solid, stable formulations of GC-C receptor agonist polypeptide suitable for oral administration are described herein as are methods for preparing such formulations. The GC-C receptor agonist polypeptide formulations described herein are stable and have a sufficient shelf life for manufacturing, storing and distributing the drug.
(FR)L'invention concerne des formulations solides stables de polypeptides agonistes vis-à-vis du récepteur GC-C se prêtant à une administration par voie orale et des procédés d'élaboration correspondants. Ces formulations sont stables et ont une durée de conservation suffisante en vue de la fabrication, du stockage et de la distribution du médicament.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)